Rapporten
Djupdykningar i företagsfinansiering, tillväxtstrategier och marknadsinsikter från världens mest innovativa företag
52 rapporter och fler
Treeline Biosciences Raises $200M in Series A
Treeline Biosciences, a HealthTech company based in San Diego, CA, has raised $200M in Series A from multiple investors.
Treeline Biosciences raises $200M Series A
Treeline Biosciences raises $200M in Series A. Developer of medicines for cancer and serious diseases, total funding $1.1B...
Treeline Biosciences Raises $421 Million in Undisclosed Round - October 17, 2024
Treeline Biosciences announced $421 Million in Undisclosed Round funding at a $1.1 Billion+ Total Raised valuation. Treeline Biosciences is a secretive biotech company focused on developing innovative cancer therapeutics using AI-powered drug discovery platforms....
Serán Bioscience Raises $200M in Venture
Serán Bioscience, a Biotech company based in Bend, OR, has raised $200M in Venture at a $900M valuation led by Foresite Capital, OrbiMed.
Retro Biosciences Raises $1B in Seed
Retro Biosciences, a HealthTech company based in San Francisco, CA, has raised $1B in Seed led by Sandro Salsano.
Syndeio Biosciences Raises $90M in Series
Syndeio Biosciences, a Biotech company based in Indianapolis, IN, has raised $90M in Series at a $450M valuation led by Eli Lilly and Company, ARCH Venture Partners.
Ollin Biosciences Raises $100M in Series A
Ollin Biosciences, a Biotech company based in Austin, TX, has raised $100M in Series A at a $500M valuation led by Deerfield Management, ARCH Venture Partners.
Colossal Biosciences Raises $120M in Series
Colossal Biosciences, a Biotech company based in Austin, TX, has raised $120M in Series at a $800M valuation led by CIA In-Q-Tel, Breyer Capital.
Merida Biosciences Raises $121M in Series A
Merida Biosciences, a Biotech company based in Cambridge, MA, has raised $121M in Series A at a $500M valuation led by Bain Capital Life Sciences, Biotechnology Value Fund, Third Rock Ventures.
Visar 9 rapporter • Sida 1 • Kategori: all
Ligga steget före marknaden
Få veckovisa insikter levererade till din inkorg. Ingen spam, bara intelligens.